EMA RELEASES WITHDRAWN MEDICINES NOTIFICATION TEMPLATE
February 1st, 2014THE EUROPEAN Medicines Agency (EMA) has released a template for declarations by European Union (EU) pharmaceutical companies who withdraw their products from sale; suspend such sales; decide not to renew a market authorisation; or reverse an earlier decision to apply for a market authorisation. Completed forms are to be submitted to EMA and affected EU member states.
*http://www.ema.europa.eu/ema/pages/includes/document/open_document.jsp?webContentId=WC500153409
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.